By integrating ongoing bioethical collaboration, neuroscientists can create a positive effect on their research and the knowledge it produces. To this end, we offer our experiences with an interdisciplinary model for the ethical advancement of a promising area of neuroscience — human neural organoid research.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Sawai, T., Sakaguchi, H., Thomas, E., Takahashi, J. & Fujita, M. Stem Cell Reports 13, 440–447 (2019).
Lopes, M. et al. Am. Sci. 109, 208–209 (2021).
Quadrato, G. et al. Nature 545, 48–53 (2017).
Andersen, J. et al. Cell 183, 1913–1929.e26 (2020).
Hyun, I., Scharf-Deering, J. C. & Lunshof, J. E. Brain Res. 1732, 146653 (2020).
Cakir, B. et al. Nat. Methods 16, 1169–1175 (2019).
Mansour, A. A. et al. Nat. Biotechnol. 36, 432–441 (2018).
Hyun, I. Cell Stem Cell 21, 718–720 (2017).
Lovell-Badge, R. et al. Stem Cell Reports 16, 1398–1408 (2021).
Acknowledgements
This project was funded by the NIH BRAIN Initiative Grant no. RF1 MH117803. I.H and J.E.L. received additional funding from the Greenwall Foundation’s ‘Making a Difference’ Grant.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
A.H.M.N. and P.K. are inventors on patents filed by the Presidents and Fellows of Harvard College and GC Therapeutics, Inc., and are co-founders of and have equity in GC Therapeutics, Inc. I.H. is a bioethics advisor for Bayer, the Novo Nordisk Foundation, and Rumi Therapeutics. P.A. is a member of the scientific advisory board at Herophilus, Rumi Therapeutics, and Foresite Labs, and is a co-founder of Vesalius. M.A.S.-S. and A.L. have submitted a patent application associated with engineered brain organoids (US Provisional Application Serial No. 63/048,502, filed July 6, 2020). Stanford University holds patents for the generation of cortical organoids/spheroids and assembloids (listing S.P.P. as an inventor). From September 1, 2021, M.P. has been an employee of Roche. G.M.C.’s competing interests are listed at https://arep.med.harvard.edu/gmc/tech.html. The remaining authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Hyun, I., Scharf-Deering, J.C., Sullivan, S. et al. How collaboration between bioethicists and neuroscientists can advance research. Nat Neurosci 25, 1399–1401 (2022). https://doi.org/10.1038/s41593-022-01187-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41593-022-01187-2